Evidence map›Paper›PMID 7609032›Full record

ArticleJournal of virology1995

Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation.

J W Dubay, S R Dubay, H J Shin, E Hunter

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. HIV envelope tail truncation confers resistance to SERINC5 restriction.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Mechanisms for Env glycoprotein acquisition by retroviruses.AIDS research and human retroviruses · 2011
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

J W DubayDepartment of Microbiology, University of Alabama at Birmingham 35294, USA.
S R Dubay
H J Shin
E Hunter
University of Alabama at Birmingham · US

Funding

STRUCTURE FUNCTION/ANALYSIS OF THE HIV ENV GENE PRODUCTR01AI033319 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HUNTER, ERIC · 2003 to 2007
$1.8M
STRUCTURE/FUNCTION ANALYSIS OF THE HIV ENV GENE PRODUCTR37AI033319 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HUNTER, ERIC · 1992 to 2001
$685k
RETROVIRAL GLYCOPROTEIN PRECURSOR CLEAVAGEP01AI027290 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HUNTER, ERIC · 1988 to 1992
–
NCI NIH HHS CA09467NIAID NIH HHS AI-27290NIAID NIH HHS AI-33319
6 · The paper itself

Abstract

Endoproteolytic cleavage of the glycoprotein precursor to the mature SU and TM proteins is an essential step in the maturation of retroviral glycoproteins. Cleavage of the precursor polyprotein occurs at a conserved, basic tetrapeptide sequence and is carried out by a cellular protease. The glycoprotein of the human immunodeficiency virus type 1 contains two potential cleavage sequences immediately preceding the N terminus of the TM protein. To determine the functional significance of these two potential cleavage sites, a series of mutations has been constructed in each site individually, as well as in combinations that altered both sites simultaneously. A majority of the mutations in either potential cleavage site continued to allow efficient cleavage when present alone but abrogated cleavage of the precursor when combined. Despite being transported efficiently to the cell surface, these cleavage-defective glycoproteins were unable to initiate cell-cell fusion and viruses containing them were not infectious. Viruses that contained glycoproteins with a single mutation, and that retained the ability to be processed, were capable of mediating a productive infection, although infectivity was impaired in several of these mutants. Protein analyses indicated that uncleaved glycoprotein precursors were inefficiently incorporated into virions, suggesting that cleavage of the glycoprotein may be a prerequisite to incorporation into virions. The substitution of a glutamic acid residue for a highly conserved lysine residue in the primary cleavage site (residue 510) had no effect on glycoprotein cleavage or function, even though it removed the only dibasic amino acid pair in this site. Peptide sequencing of the N terminus of gp41 produced from this mutant glycoprotein demonstrated that cleavage continued to take place at this site. These results, demonstrating that normal cleavage of the human immunodeficiency virus type 1 glycoprotein can occur when no dibasic sequence is present at the cleavage site, raise questions about the specificity of the cellular protease that mediates this cleavage and suggest that cleavage of the glycoprotein is required for efficient incorporation of the glycoprotein into virions.

Indexed as

Amino Acid SequenceAnimalsBinding SitesBiotinCell LineFluorescent Antibody TechniqueHIV-1HumansHydrolysisMembrane GlycoproteinsMolecular Sequence DataMutagenesis, Site-DirectedPrecipitin TestsProtein PrecursorsViral Envelope ProteinsVirionBiotinMembrane GlycoproteinsProtein PrecursorsViral Envelope Proteins

Identifiers

PMID7609032
PMCPMC189271
OpenAlexW1708167719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.